Zymeworks (ZYME) Non-Current Deffered Revenue (2021 - 2026)

Zymeworks (ZYME) has 6 years of Non-Current Deffered Revenue data on file, last reported at $14.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deffered Revenue changed 0.01% year-over-year to $14.6 million; the trailing twelve-month figure through Mar 2026 stood at $14.6 million (changed 0.01% YoY), and the FY2025 full-year result was $14.6 million, changed 0.01% from the prior year.
• Non-Current Deffered Revenue was little changed at $14.6 million in Q1 2026, from $14.6 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $32.9 million in Q3 2022 to a low of $14.6 million in Q4 2025.
• A 5-year average of $23.9 million and a median of $30.6 million in 2022 frame the typical range for Non-Current Deffered Revenue.
• Across the five-year window, Non-Current Deffered Revenue grew 7.69% in 2023 and tumbled 55.66% in 2024, its largest moves.
• Tracing ZYME's Non-Current Deffered Revenue over 5 years: stood at $30.6 million in 2022, then climbed by 7.69% to $32.9 million in 2023, then plunged by 55.66% to $14.6 million in 2024, then declined by 0.01% to $14.6 million in 2025, then changed by 0.0% to $14.6 million in 2026.
• Business Quant data shows ZYME's Non-Current Deffered Revenue at $14.6 million in Q1 2026, $14.6 million in Q4 2025, and $14.6 million in Q3 2025.